April 17, 2024
Aesthetic Injectables Market

Aesthetic Injectables Market is Estimated to Witness High Growth Owing to Rising Popularity of Minimally Invasive Procedures.

Aesthetic injectables are minimally invasive cosmetic products injected into the skin to reduce wrinkles, lift drooping skin or augment soft tissue contours. Advancements in dermal filler formulations and availability of natural and synthetic fillers have increased customer acceptance. Hyaluronic acid and botulinum toxin are commonly used aesthetic injectables for correcting crow’s feet, frown lines, lip augmentation and reduction of double chin. The ease of administering and immediate effectiveness of aesthetic injectables have made them popular among consumers looking for subtle anti-aging benefits.

The global aesthetic injectables market is estimated to be valued at US$ 19.76 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031.

Key Takeaways
Key players operating in the aesthetic injectables are AbbVie, Galderma, Merz Pharma, Teoxane Laboratories, Sinclair Pharma, Suneva Medical, Croma-Pharma GmbH, Luminera Derm, Johnson & Johnson, Revance Therapeutics, Hyaltech Ltd, Bioxis Pharmaceuticals, Prollenium Medical Technologies, SciVision Biotech Inc., and Bloomage BioTechnology Corporation Ltd.

The key opportunities in the Aesthetic Injectables Market Size include increasing availability of natural and synthetic dermal filler options, growing medical tourism in emerging economies and rising disposable incomes allowing consumers to spend more on aesthetic treatments.

Technological advancements such as the development of biodegradable hyaluronic acid fillers, combination injectables and protein-based dermal fillers are expanding the choices available to aesthetic physicians and their patients.

Market Drivers
The rising popularity of minimally invasive cosmetic procedures due to their quick recovery time and less pain is a key driver for the aesthetic injectables market. The desire to maintain youthful appearance and growing awareness about new aesthetic treatments among the middle-aged population further accelerates the market growth. Additionally, rising marketing campaigns by injectable manufacturers and increasing social acceptance of cosmetic enhancements are also fueling the demand for aesthetic injectables.

Current challenges in the Aesthetic Injectables Market:
Some of the major challenges faced by the aesthetic injectables market are lack of proper understanding of the products, societal perception and stigma related to cosmetic procedures, risk of side effects, pricing issues of the products and lack of skilled professionals. Many societies still view aesthetic procedures with skepticism and associate them with vanity or shallowness which acts as a barrier. Risks associated with botched procedures or adverse side effects needs to be properly addressed to boost consumer confidence. Managing pricing points to make products affordable yet viable for businesses is another challenge. Shortage of trained professionals poses hurdles in scaling up service delivery.

SWOT Analysis
Strength: Improved materials and techniques have enhanced safety and efficacy of products. Growing social acceptance making market more mainstream.
Weakness: Over-dependence on few popular products. Perceived risks associated may limit consumer base.
Opportunity: Expanding into new geographies and underpenetrated segments with education campaigns. Emerging technologies can further enhance products.
Threats: Economic slowdowns impacting discretionary spends. Stringent regulations may increase compliance costs.

Geographically, North America accounts for the largest share currently owing to factors such as high disposable incomes, awareness and social acceptance of procedures. However, Asia Pacific region is expected to witness the fastest growth during the forecast period supported by growing middle class, medical tourism and efforts of companies to tap untapped potential in markets like India, China and Southeast Asia.

The United States holds the leading position currently within the aesthetic injectables market owing to factors such as highest per capita spending on aesthetic procedures, availability of advanced medical facilities and growing influence of social media spurring beauty consciousness. But China is likely to experience exponential gains becoming the fastest growing regional market by 2029 impacted by rapidly changing lifestyle aspirations, growing focus on external appearance and proliferation of aesthetic service providers.

1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it